Day 1: AI/ML & Emerging Technologies in Antibody-based Molecular Engineering
Day 2: Towards Optimising Antibody-Based Therapeutics And Modes Of Action
Pragya Shah, Senior Scientist, AbbVie
Melissa Damschroder, Senior Director R&D, AstraZeneca
Francois Bertelli, Head of Antibody Research, 272BIO Limited
Andrew Goodearl, Senior Director, AbbVie
Generated by meetings and positions 5.0 by Kai Garlipp WWW: Kai Garlipp, Frank S. Zollmann. 7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.